Today: 7 April 2026
Subscribe
Browse Category

Earnings Reports 5 January 2026

TSMC stock jumps in premarket after Goldman target hike — what investors watch before earnings

TSMC stock jumps in premarket after Goldman target hike — what investors watch before earnings

Taiwan Semiconductor’s U.S. shares rose 3.4% premarket Monday after Goldman Sachs raised its target price, citing strong AI-driven demand and tight chip supply. The stock hit a 52-week high Friday, closing up 5.2%. TSMC enters a quiet period ahead of December sales and Q4 results due Jan. 9 and Jan. 15. Taiwanese prosecutors filed new indictments over alleged TSMC trade secret theft.
5 January 2026
··
Anglo American stock jumps 3% in London as metals rally; merger clock and Feb. 5 report in focus

Anglo American stock jumps 3% in London as metals rally; merger clock and Feb. 5 report in focus

Anglo American shares jumped 3.1% to 3,133 pence early Monday, tracking gains in metals and after shareholders approved a $53 billion merger with Teck Resources. Gold surged 2.2% to $4,424.17 an ounce after the U.S. captured Venezuela’s president, while iron ore and copper prices also firmed. Regulatory approval remains pending for the Anglo-Teck deal. Investors await Anglo’s Q4 production report on Feb. 5.
5 January 2026
··
MercadoLibre stock slides into 2026 as MELI investors eye Feb. 24 earnings and a big U.S. data week

MercadoLibre stock slides into 2026 as MELI investors eye Feb. 24 earnings and a big U.S. data week

MercadoLibre Inc shares fell 2.0% to $1,973.70 on Friday, closing about $110 below their 50-day moving average and $294 under the 200-day. The drop outpaced U.S. benchmarks as the company heads into its first full trading week under new CEO Ariel Szarfsztejn. Investors await Monday’s ISM data and the December jobs report later in the week. Fourth-quarter results are scheduled for Feb. 24.
5 January 2026
··
Applied Digital stock (APLD) jumps 15% into earnings week as ChronoScale spin-out plan sharpens focus

Applied Digital stock (APLD) jumps 15% into earnings week as ChronoScale spin-out plan sharpens focus

Applied Digital shares surged 14.6% to close at $28.11 Friday on heavy volume. The company will report fiscal Q2 results after markets close Jan. 7 and hold a conference call at 5 p.m. ET. Investors await updates on a proposed cloud business spin-out with Ekso Bionics and new financing for AI-focused data centers. A subsidiary secured up to $100 million in credit from Macquarie Equipment Capital at 8% interest.
5 January 2026
···
Workday (WDAY) stock hugs 52-week low after Friday slide as focus shifts to jobs data, next earnings

Workday (WDAY) stock hugs 52-week low after Friday slide as focus shifts to jobs data, next earnings

Workday shares dropped 4.2% to $205.79 on Friday, hitting a 52-week low of $202.22. The decline came as the S&P 500 rose 0.19% and investors watched interest-rate moves. Workday’s fiscal fourth-quarter results are due in late February, with subscription growth and guidance in focus. The company’s planned acquisition of Pipedream is expected to close this quarter.
5 January 2026
··
IBM stock slips below $300 as Wall Street braces for jobs data and Big Blue earnings

IBM stock slips below $300 as Wall Street braces for jobs data and Big Blue earnings

IBM shares closed down 1.6% at $291.50 Friday, falling below $300 after touching $289.00 intraday. The move comes ahead of key U.S. jobs and inflation data next week and IBM’s preliminary fourth-quarter earnings set for Jan. 28. Directors Michael Miebach and Peter R. Voser deferred fees into stock units, according to SEC filings. IBM sits about 10% below its 52-week high of $324.90.
5 January 2026
··
Costco stock drifts near 52-week low ahead of December sales report — here’s what matters next

Costco stock drifts near 52-week low ahead of December sales report — here’s what matters next

Costco shares closed Friday down 0.9% at $854.50, near a 52-week low ahead of December sales results due Jan. 7. Analyst Joseph Feldman expects December comparable sales growth to slow to 2.2% from 7.4% last year. The stock remains below key technical levels and lags the broader market. Gasoline prices and currency shifts are expected to impact reported figures.
5 January 2026
··
Mastercard stock slides into 2026 after four-day skid; jobs report and earnings date loom

Mastercard stock slides into 2026 after four-day skid; jobs report and earnings date loom

Mastercard shares fell 1.36% to $563.13 on Friday, marking a fourth consecutive decline and closing about 6% below their 52-week high. Trading volume was above average as investors await the U.S. jobs report on Jan. 9 and Mastercard’s expected earnings on Jan. 29. Visa also slipped, while major banks gained. Mastercard’s board declared a quarterly dividend and approved a $14 billion buyback.
5 January 2026
··
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
5 January 2026
····
1 … 141 142 143 144 145 … 229

Stock Market Today

  • ImageneBio (IMA) Shares Drop 8.5% Amid Mixed Analyst Ratings
    April 7, 2026, 3:50 AM EDT. ImageneBio, Inc. (NASDAQ:IMA) shares fell 8.5% on Monday to $4.55 on low volume, down 68% from average daily trading. The biotech, focused on immunological therapies, reports a negative price-to-earnings ratio of -0.56 and trades below its 50- and 200-day moving averages. Wall Street Zen recently upgraded the stock from 'strong sell' to 'hold.' Analyst consensus remains a "Hold" with an average price target of $26.50. Hedge funds, including Barclays and Goldman Sachs, have increased or initiated positions recently. The firm reported $0.34 EPS last quarter but is forecast to post -0.91 EPS this year. ImageneBio's lead candidate, IMG-007, targets atopic dermatitis and alopecia areata in Phase 2a trials.
Go toTop